Reportedly, complement could be activated in tumor tissues [2, 30, 31], and lung cancer cells could also generate C5a [3], creating a microenvironment for NSCLC growth and proliferation [11, 12, 30]. The gene discussed is C5AR1; the disease is non-small cell lung carcinoma.